Hans Keirstead
Chairman and Chief Executive Officer at AIVITA Biomedical and Chairman of the Board at Immunis
Dr. Keirstead is an internationally known stem cell expert and serial entrepreneur that led the development of a treatment that restored movement and sensory function to people with quadriplegic spinal cord injury, and a treatment for cancer that has saved the lives of people with melanoma, brain cancer and ovarian cancer. He has also led therapy development for immune disorders, motor neuron diseases and retinal diseases, as well as a vaccine for COVID-19. He has founded 4 successful biotechnology companies, each returning significant value to investors and treatments to patients. Every one of his prior companies has sold to large or mid-sized pharmaceutical companies for 2.5X-9.5X returns to investors, after return of investment capital. Dr. Keirstead holds Board positions in several prominent biotechnology companies.
Visit website: https://immunisbiomedical.com/about/hans-s-keirstead-ph-d/
See also:
Immunis
- Biotechnology company changing the course of immune-related diseases and ageing
Details last updated 21-Oct-2022
Hans Keirstead is also referenced in the following:
Age-Related Disease Therapeutics Summit
31-May-2023 to 02-Jun-2023
Event about aging and aging related diseases organized by Hanson Wade
Hans Keirstead News
Reason reports back from Age-Related Disease Therapeutics Summit 2023
Fight Aging! - 16-Jun-2023
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Read more...Reason reports back from October's Rejuvenation Startup Summit
Fight Aging! - 19-Oct-2022
Some really exciting developments with quite a few in clinical trials
Read more...